Fitterfly's X-Labs division revolutionizes chronic disease management through AI and personalized data analysis, enhancing patient care for superior health outcomes.
Fitterfly, a health-tech startup, has launched a new division called X-Labs on its 7th Anniversary. X-Labs focuses on transforming chronic disease management using AI, Human-centered Design, and digital therapeutics.
Fitterfly has developed a unique care continuum model that assigns dedicated nutritionists, physiotherapists, and psychologists to each member. By combining technologies like continuous glucose sensing and digital therapeutics, Fitterfly has achieved outcomes for over 20,000 individuals fighting diabetes and obesity. These results include an average reduction of 1.96% in HbA1c levels, weight loss, and improvements in overall fitness, sleep quality, and stress reduction.
X-Labs has two primary missions. The first mission focuses on AI Coaching and Chatbots. Fitterfly's chatbots have been engaging subscribers since 2016 and have delivered over 22 million positive nudges. With X-Labs, AI will take on progress monitoring, reminders, common queries, and routine information, while human coaches provide personalized care beyond previous capabilities.
The second mission involves leveraging personalized data analysis and hybrid workflows to unlock the potential of data. Fitterfly will empower clients with insightful health journey understanding and actionable steps, using virtual biomarkers to complement glucose levels through biofeedback loops. This approach allows Fitterfly's health professionals to prioritize human-centric tasks, optimize care, and emphasize empathy.
Dr Arbinder Singal, CEO and Co-Founder of Fitterfly, highlighted the significance of the launch, stating-
“Diabetes is a huge problem to solve in India. With the use of AI, we can help more people instantly. Our interactions with our members have provided deep insights and data, which we plan to leverage to create new biomarkers and instant help tools. At Fitterfly, we constantly strive to push the envelope and revolutionize the management of chronic diseases.”
Ammar J, Head of X-Labs at Fitterfly emphasized the commitment to innovation saying-
“X-Labs embodies Fitterfly’s dedication to patient outcomes. By utilizing algorithmic insights and virtual biomarkers rooted in evidence-based medicine, we are reimagining the care continuum. Our goal is to make a lasting impact on chronic disease management and redefine care pathways.”
Fitterfly's X-Labs division represents a paradigm shift in chronic disease management. With the utilization of AI-driven chatbots and personalized data analysis, Fitterfly strives to redefine the realm of patient care and attain exceptional health outcomes.
Resource- https://www.healthcareradius.in/features/digital-healthcare/fitterfly-launches-x-labs-digital-therapeutics-for-chronic-disease-management